T1	Participants 121 189	patients <65 years with poor prognosis histologically aggressive NHL
T2	Participants 192 224	This trial involved 457 patients
T3	Participants 286 397	autologous transplantation in patients with poor prognosis histologically aggressive non-Hodgkin lymphoma (NHL)
T4	Participants 559 618	223 assigned to continuing CHOP and 234 to 3 cycles of CHOP
